首页> 外文期刊>global & regional health technology assessment >Clinical opportunities and healthcare impact of optimal treatment in the post-ACS patient
【24h】

Clinical opportunities and healthcare impact of optimal treatment in the post-ACS patient

机译:ACS 后患者最佳治疗的临床机会和医疗保健影响

获取原文
获取原文并翻译 | 示例

摘要

Despite the improvement of revascularization procedures, patients with acute coronary syndrome often develop recurrent ischemic events, suggesting a high residual cardiovascular risk in these patients, which requires a strict clinical monitoring as well as an optimal control of modifiable risk factors. To this aim, an optimal management of index event and appropriate preventive measures are equally important. Hospital care by cardiologists should be followed by outpatient management by general practitioners, as established by specific diagnostic and therapeutic pathways, which should warrant an optimal support to the patient. A strict collaboration between hospital and primary care is crucial to monitor and adapt drug therapy after the acute event and improve adherence of the patients to prescribed treatments and implementation of life-style modifications, with benefits also in term of cost-effectiveness. In this context, individualized rehabilitation programs should also be offered to patients with acute coronary syndromes, in order to improve survival and quality of life.
机译:尽管血运重建程序有所改善,但急性冠脉综合征患者经常发生复发性缺血事件,这表明这些患者的残余心血管风险很高,这需要严格的临床监测以及对可改变的危险因素进行最佳控制。为此,指标事件的最佳管理和适当的预防措施同样重要。在心脏病专家的住院治疗之后,应由全科医生进行门诊管理,这些管理应由特定的诊断和治疗途径确定,这应该保证为患者提供最佳支持。医院和初级保健机构之间的密切合作对于在急性事件发生后监测和调整药物治疗以及提高患者对处方治疗的依从性和生活方式改变的实施至关重要,这在成本效益方面也有好处。在这种情况下,还应为急性冠脉综合征患者提供个体化的康复计划,以提高生存率和生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号